Showing 3081-3090 of 4166 results for "".
- Eyedaptic Unveils EYE7 Smart Glasseshttps://modernod.com/news/eyedaptic-unveils-eye7-smart-glasses/2486374/Key Takeaways Eyedaptic has launched the EYE7 smart glasses with integrated AI visual assistants. The EYE7 reportedly provides lightweight comfort, personalized visual modes, and enhanced acuity/contrast for users with vision impairments. The Eyedap
- NextGen Healthcare Expands Eye Care Solutions Through Strategic Alignment with Eyefinityhttps://modernod.com/news/nextgen-healthcare-expands-eye-care-solutions-through-strategic-alignment-with-eyefinity/2484213/NextGen Healthcare said it is enhancing its suite of offerings for optometrists and ophthalmologists through a new alignment with Eyefinity, a VSP Vision company. According to NextGen, the new collaboration will d
- American Academy of Optometry Announces 2025 Award Recipientshttps://modernod.com/news/american-academy-of-optometry-announces-2025-award-recipients/2484131/Each year, the American Academy of Optometry (AAOpt) recognizes distinguished individuals whose contributions advance the profession of optometry and vision science. The Academy’s awardees are nominated by fellows and are based on contributions made in t
- LKC Technologies: RETeval DR Score Superior in Predicting Diabetic Retinopathy Outcomeshttps://modernod.com/news/lkc-technologies-reteval-dr-score-superior-in-predicting-diabetic-retinopathy-outcomes/2482924/LKC Technologies, a provider of electroretinography (ERG)-based functional diagnostics, announced the publication of a study that found that ERG/pupillometry outperforms structural imaging in identifying patients at highest risk of progressing to vision-t
- Boehringer Ingelheim and Re-Vana Therapeutics Collaborate to Develop Long-Acting Ophthalmic Therapieshttps://modernod.com/news/boehringer-ingelheim-and-re-vana-therapeutics-announce-collaboration-to-develop-long-acting-ophthalmic-therapies/2482905/Boehringer Ingelheim and Re-Vana Therapeutics announced a strategic collaboration and license agreement designed to accelerate the development of first-in-class extended-release therapies for vision-threatening eye diseases.
- NIH Researchers Identify Brain Circuits Responsible for Visual Acuityhttps://modernod.com/news/nih-researchers-identify-brain-circuits-responsible-for-visual-acuity/2482836/Researchers at the National Institutes of Health (NIH) says they have identified specific brain circuits vital to visual acuity and uncovered how these circuits are disrupted by damage to retinal cells, a discovery that could reshape the future of vision resto
- The Alliance for Healthcare from the Eye Launches to Transform Disease Detectionhttps://modernod.com/news/the-alliance-for-healthcare-from-the-eye-launches-to-transform-disease-detection/2482801/A coalition of healthcare leaders announced the launch of the 'Alliance for Healthcare from the Eye (AHE)' at the Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City. AHE is a cross-sector initiative
- FDA Approves Neurotech's Encelto as First and Only FDA-Approved Treatment for MacTelhttps://modernod.com/news/fda-approves-neurotechs-encelto-as-first-and-only-fda-approved-treatment-for-mactel/2482690/Neurotech Pharmaceuticals announced that the FDA has approved Encelto (revakinagene taroretcel-lwey) for the treatment of Macular Telangiectasia type 2 (MacTel). MacTel is a neurodegenerative disease of the retina in adults that causes progressive and irreversible vision
- Resolving a Seeming Contradiction, Study Advances Understanding of Visual Recognition Memoryhttps://modernod.com/news/resolving-a-seeming-contradiction-study-advances-understanding-of-visual-recognition-memory/2481866/Researchers from The Picower Institute for Learning and Memory have published a study evaluating how our vision is so good at recognizing what’s familiar. The study, published in the Journa
- Study Uncovers Novel Synaptic Intricacies Inside the Retinahttps://modernod.com/news/study-uncovers-novel-synaptic-intricacies-inside-the-retina/2481687/A Northwestern Medicine study has uncovered novel cellular mechanisms within the retina, findings that researchers say could help advance the development of targeted therapeutics for diseases and conditions impacting vision. The findings were